Total Current Liabilities

$5.53B

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$5.53Bperiod endingJun 30, 2026

REGN Quarterly Current Liabilities ($1.80M → $5.53B)

Quarterly total current liabilities

High-resolution chart · PNG

REGN total current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Total Current Liabilities — Quarterly (USD)
Period ending	Total Current Liabilities (USD)
Jun 30, 2001	12,926,000
Mar 31, 2001	13,855,000
Dec 31, 2000	13,786,000
Sep 30, 2000	12,742,000
Jun 30, 2000	13,027,000
Mar 31, 2000	12,450,000
Dec 31, 1999	13,300,000
Sep 30, 1999	8,900,000
Jun 30, 1999	8,700,000
Mar 31, 1999	9,900,000
Dec 31, 1998	9,400,000
Sep 30, 1998	9,600,000
Jun 30, 1998	8,500,000
Mar 31, 1998	7,500,000
Dec 31, 1997	10,700,000
Sep 30, 1997	7,800,000
Jun 30, 1997	10,800,000
Mar 31, 1997	9,700,000
Dec 31, 1996	12,000,000
Sep 30, 1996	8,900,000
Jun 30, 1996	9,600,000
Mar 31, 1996	10,500,000
Dec 31, 1995	12,900,000
Sep 30, 1995	14,100,000
Jun 30, 1995	16,200,000
Mar 31, 1995	13,700,000
Dec 31, 1994	17,900,000
Sep 30, 1994	16,500,000
Jun 30, 1994	21,700,000
Mar 31, 1994	11,000,000
Dec 31, 1993	13,100,000
Sep 30, 1993	9,400,000
Jun 30, 1993	7,400,000
Mar 31, 1993	6,200,000
Dec 31, 1992	4,600,000
Sep 30, 1992	5,300,000
Jun 30, 1992	4,200,000
Mar 31, 1992	4,000,000
Dec 31, 1991	3,300,000
Sep 30, 1991	2,100,000
Jun 30, 1991	2,000,000
Dec 31, 1990	1,800,000